GSK’s Academic Collaborations Net Several Prospective Pipeline Drugs

A A
GlaxoSmithKline is close to designating several new chemicals ready for clinical research as a result of successful collaborations with academia, the drugmaker said Nov. 6.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00